Regencell Bioscience Holdings Ltd
RGC
View Detailed Chart
11.280USD
-0.400-3.42%
Close 11/25, 16:00（ET）Quotes delayed by 15 min
5.58BMarket Cap
--P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-3.42%
5 Days
-13.83%
1 Month
-29.06%
6 Months
-97.99%
Year to Date
+128.34%
1 Year
+91.02%
View Detailed Chart
TradingKey Stock Score of Regencell Bioscience Holdings Ltd
Currency: USD Updated: 2025-10-27Key Insights
Its valuation is considered undervalued,and institutional recognition is low. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Regencell Bioscience Holdings Ltd's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
0
analysts
--
Current Rating
0.000
Target Price
0.00%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Regencell Bioscience Holdings Ltd Highlights
StrengthsRisks
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Undervalued
The company’s latest PE is -1996.37, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 680.91K shares, increasing 32.86% quarter-over-quarter.
Regencell Bioscience Holdings Ltd News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Regencell Bioscience Holdings Ltd Info
Regencell Bioscience Holdings Ltd is a bioscience company that focuses on research, development and commercialization of traditional Chinese medicine (TCM) for the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). The Company launches three liquid based standardized TCM formulae candidates for mild, moderate and severe ADHD and ASD patients.
Ticker SymbolRGC
CompanyRegencell Bioscience Holdings Ltd
CEO
Websitehttps://www.regencellbioscience.com/
FAQs
What is the current price of Regencell Bioscience Holdings Ltd (RGC)?
The current price of Regencell Bioscience Holdings Ltd (RGC) is 11.280.
What is the symbol of Regencell Bioscience Holdings Ltd?
The ticker symbol of Regencell Bioscience Holdings Ltd is RGC.
What is the 52-week high of Regencell Bioscience Holdings Ltd?
The 52-week high of Regencell Bioscience Holdings Ltd is 83.600.
What is the 52-week low of Regencell Bioscience Holdings Ltd?
The 52-week low of Regencell Bioscience Holdings Ltd is 0.093.
What is the market capitalization of Regencell Bioscience Holdings Ltd?
The market capitalization of Regencell Bioscience Holdings Ltd is 5.58B.
What is the net income of Regencell Bioscience Holdings Ltd?
The net income of Regencell Bioscience Holdings Ltd is -3.58M.
Is Regencell Bioscience Holdings Ltd (RGC) currently rated as Buy, Hold, or Sell?
According to analysts, Regencell Bioscience Holdings Ltd (RGC) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Regencell Bioscience Holdings Ltd (RGC)?
The Earnings Per Share (EPS TTM) of Regencell Bioscience Holdings Ltd (RGC) is -0.008.
Related Instruments
+3.72%
+0.30%
+1.00%
+1.88%
+5.24%
+2.94%
+2.04%
+4.65%
+1.48%
+1.98%
+2.30%
+2.19%
+1.37%
+2.70%
+1.19%
+1.55%
+3.40%
0.00%
-1.02%
+4.09%Popular Symbols
